Literature DB >> 9765601

cDNA cloning and expression of a novel serine protease, TLSP.

S Yoshida1, M Taniguchi, T Suemoto, T Oka, X He, S Shiosaka.   

Abstract

A cDNA for a putative novel serine protease, TLSP, was cloned from human hippocampus cDNA with polymerase chain reaction based strategies. The putative amino acid sequence of TLSP is similar to the trypsin-type serine proteases. TLSP mRNA is expressed in keratinocytes. Overexpressed TLSP protein in neuro2a cells was detected in culture medium.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9765601     DOI: 10.1016/s0167-4781(98)00116-x

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  5 in total

1.  Butyrylcholinesterase-Mediated enhancement of the enzymatic activity of trypsin.

Authors:  S Darvesh; R Kumar; S Roberts; R Walsh; E Martin
Journal:  Cell Mol Neurobiol       Date:  2001-06       Impact factor: 5.046

2.  KLK11 suppresses cellular proliferation via inhibition of Wnt/β-catenin signaling pathway in esophageal squamous cell carcinoma.

Authors:  Xin He; Fan Meng; Lingyu Qin; Zhile Liu; Xiongjie Zhu; Zhongjian Yu; Yanfang Zheng
Journal:  Am J Cancer Res       Date:  2019-10-01       Impact factor: 6.166

3.  Over-expression of human kallikrein 11 is associated with poor prognosis in patients with low rectal carcinoma.

Authors:  Xiao Yu; Hua Yong Tang; Xiao Rong Li; Xiao Wen He; Kai Min Xiang
Journal:  Med Oncol       Date:  2009-01-29       Impact factor: 3.064

4.  Knockdown of KLK11 reverses oxaliplatin resistance by inhibiting proliferation and activating apoptosis via suppressing the PI3K/AKT signal pathway in colorectal cancer cell.

Authors:  Yiyi Zhang; Zongbin Xu; Yanwu Sun; Pan Chi; Xingrong Lu
Journal:  Onco Targets Ther       Date:  2018-02-16       Impact factor: 4.147

5.  Kallikrein gene downregulation in breast cancer.

Authors:  G M Yousef; G M Yacoub; M-E Polymeris; C Popalis; A Soosaipillai; E P Diamandis
Journal:  Br J Cancer       Date:  2004-01-12       Impact factor: 7.640

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.